Arteriocyte (Now Isto Biologics)

Isto Biologics is a medical company focused on orthobiologic solutions that enhance patient outcomes in bone regeneration, spine, orthopedics, and sports medicine. Established in 2016 through the merger of Isto Technologies and Arteriocyte Medical Systems, the company is headquartered in St. Louis, with additional operations in Massachusetts. Isto Biologics is committed to providing innovative biologic therapies and bone graft products that support faster healing. The company offers a range of products, including the Magellan® Autologous Concentration System for preparing autologous therapies, and the InQu® Bone Graft Extender & Substitute, which promotes faster bone fusion. Their cell therapy solutions, such as the CellPoint® system, support cell-based therapies for bone regeneration. Isto Biologics serves a diverse customer base, including physicians, surgeons, distributors, hospital administrators, and researchers, all seeking effective biologic solutions for improved patient care.

• Employees 19